Home › Compare › EMMLF vs EPRT

EMMLF vs EPRT: Dividend Comparison 2026

EMMLF yields 14598.54% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMMLF wins by $2315127447129181184.00M in total portfolio value
10 years
EMMLF
EMMLF
● Live price
14598.54%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2315127447129181184.00M
Annual income
$2,284,345,916,069,374,600,000,000.00
Full EMMLF calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — EMMLF vs EPRT

📍 EMMLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMMLFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMMLF + EPRT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EMMLF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMMLF
Annual income on $10K today (after 15% tax)
$1,240,875.91/yr
After 10yr DRIP, annual income (after tax)
$1,941,694,028,658,968,500,000,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, EMMLF beats the other by $1,941,694,028,658,968,500,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMMLF + EPRT for your $10,000?

EMMLF: 50%EPRT: 50%
100% EPRT50/50100% EMMLF
Portfolio after 10yr
$1157563723564590592.00M
Annual income
$1,142,172,958,034,687,300,000,000.00/yr
Blended yield
98.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

EMMLF
No analyst data
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMMLF buys
0
EPRT buys
0
No recent congressional trades found for EMMLF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMMLFEPRT
Forward yield14598.54% ✓3.92%
Annual dividend / share$2.00 ✓$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29% ✓
Portfolio after 10y$2315127447129181184.00M ✓$63.4K
Annual income after 10y$2,284,345,916,069,374,600,000,000.00 ✓$12,840.73
Total dividends collected$2313090038871241728.00M ✓$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: EMMLF vs EPRT ($10,000, DRIP)

YearEMMLF PortfolioEMMLF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$1,470,554$1,459,854.01$11,205$505.18+$1.46M → EMMLF
2$202,208,463$200,634,970.27$12,672$682.46+$202.20M → EMMLF
3$25,999,823,322$25,783,460,266.67$14,490$930.48+$25999.81M → EMMLF
4$3,126,155,661,671$3,098,335,850,716.16$16,786$1,282.69+$3126155.64M → EMMLF
5$351,509,831,288,492$348,164,844,730,504.60$19,753$1,791.56+$351509831.27M → EMMLF
6$36,963,217,951,789,784$36,587,102,432,311,096.00$23,677$2,541.64+$36963217951.77M → EMMLF
7$3,635,193,394,947,107,000$3,595,642,751,738,691,600.00$29,008$3,672.99+$3635193394947.08M → EMMLF
8$334,373,707,794,473,750,000$330,484,050,861,880,400,000.00$36,463$5,425.08+$334373707794473.69M → EMMLF
9$28,767,786,037,201,900,000,000$28,410,006,169,861,807,000,000.00$47,238$8,221.57+$28767786037201900.00M → EMMLF
10$2,315,127,447,129,181,000,000,000$2,284,345,916,069,374,600,000,000.00$63,385$12,840.73+$2315127447129181184.00M → EMMLF

EMMLF vs EPRT: Complete Analysis 2026

EMMLF — Stock

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Full EMMLF Calculator →

EPRT — REIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this EMMLF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMMLF vs SCHDEMMLF vs JEPIEMMLF vs OEMMLF vs KOEMMLF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.